Morgan Stanley Global Endurance I holds a quantitatively derived Bronze Morningstar Medalist Rating. The rating reflects that it has scored better than the norm on factors Morningstar research associates with future outperformance relative to category peers.
Morgan Stanley Global Endurance Portfolio Class I MSJIX
- NAV / 1-Day Return $20.50 / −0.58 %
- Fund Size $13.7M
- Adjusted Expense Ratio 1.000%
- Net Expense Ratio 1.000%
- Fee Level: Distribution Average
- Share Class Type Institutional
- Morningstar Category Global Small/Mid Stock
- Equity Style Box (Funds) Small Value
- Minimum Initial Investment $1M
- Investment Status Open
- TTM Yield 0.53%
- Turnover Ratio 176%
Morningstar’s Analysis MSJIX
Will MSJIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 61.2
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Victoria PLC | 18.88 | 3M | Consumer Cyclical |
Roivant Sciences Ltd Ordinary Shares | 7.19 | 1M | Healthcare |
Arbutus Biopharma Corp | 5.45 | 893,410 | Healthcare |
QXO Inc | 4.95 | 811,918 | Industrials |
Immunovant Inc | 4.81 | 789,056 | Healthcare |
Floor & Decor Holdings Inc Class A | 4.78 | 784,383 | Consumer Cyclical |
Teleflex Inc | 4.08 | 668,279 | Healthcare |
Royalty Pharma PLC Class A | 3.79 | 621,087 | Healthcare |
DraftKings Inc Ordinary Shares - Class A | 3.66 | 600,556 | Consumer Cyclical |
Calumet Inc | 3.59 | 589,071 | Basic Materials |